Connection

Karel Kostev to Drug Substitution

Back to Details
This is a "connection" page, showing publications Karel Kostev has written about Drug Substitution.
Karel Kostev
Connection Strength
0.944
Drug Substitution
  1. Prevalence of switching from two anti-TNF biosimilars back to biologic reference products in Germany?. Int J Clin Pharmacol Ther. 2019 Jun; 57(6):323-328.
    View in: PubMed
    Score: 0.599
  2. Change in glucose-lowering medication regimens in individuals with type 2 diabetes mellitus during the COVID-19 pandemic in Germany. Diabetes Obes Metab. 2021 04; 23(4):910-915.
    View in: PubMed
    Score: 0.167
  3. Switching the manufacturer of antiepileptic drugs is associated with higher risk of seizures: A nationwide study of prescription data in Germany. Ann Neurol. 2018 12; 84(6):918-925.
    View in: PubMed
    Score: 0.144
  4. Treatment patterns and low-density lipoprotein cholesterol (LDL-C) goal attainment among patients receiving high- or moderate-intensity statins. Clin Res Cardiol. 2018 May; 107(5):380-388.
    View in: PubMed
    Score: 0.034
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.